Proficio Capital Partners LLC Makes New $719,000 Investment in Simulations Plus, Inc. (NASDAQ:SLP)

Proficio Capital Partners LLC bought a new position in Simulations Plus, Inc. (NASDAQ:SLP) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 25,770 shares of the technology company’s stock, valued at approximately $719,000. Proficio Capital Partners LLC owned about 0.13% of Simulations Plus as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Conestoga Capital Advisors LLC grew its position in shares of Simulations Plus by 15.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company’s stock worth $62,090,000 after acquiring an additional 290,414 shares during the last quarter. Tributary Capital Management LLC boosted its stake in Simulations Plus by 21.7% during the 4th quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company’s stock valued at $11,047,000 after purchasing an additional 70,526 shares during the period. Stephens Inc. AR bought a new position in Simulations Plus in the 4th quarter worth about $905,000. BNP Paribas Financial Markets increased its stake in shares of Simulations Plus by 402.9% in the third quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock valued at $1,279,000 after purchasing an additional 32,002 shares during the period. Finally, State Street Corp raised its holdings in shares of Simulations Plus by 4.7% during the third quarter. State Street Corp now owns 640,303 shares of the technology company’s stock valued at $20,503,000 after buying an additional 28,953 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Insider Buying and Selling at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the transaction, the director now owns 3,402,584 shares of the company’s stock, valued at $115,381,623.44. This represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 19.40% of the company’s stock.

Wall Street Analysts Forecast Growth

SLP has been the subject of several research analyst reports. KeyCorp upped their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $49.40.

Simulations Plus Price Performance

NASDAQ SLP opened at $25.56 on Friday. Simulations Plus, Inc. has a fifty-two week low of $24.00 and a fifty-two week high of $51.22. The stock’s 50-day moving average is $31.29 and its two-hundred day moving average is $30.88. The firm has a market cap of $513.55 million, a P/E ratio of 63.90 and a beta of 0.89.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.